| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $174.1M | — | +12.3% |
| Cost of Revenue | $38.9M | — | +1.1% |
| Gross Profit | $135.1M | — | +16.0% |
| R&D Expense | $58.3M | — | +8.5% |
| SG&A Expense | $85.9M | — | +91.8% |
| Operating Income | -$67.4M | — | -78.1% |
| Pre-tax Income | -$69.3M | — | -128.6% |
| Income Tax | $1.9M | — | -53.3% |
| Net Income | -$71.1M | — | -107.3% |
| EPS (Basic) | -$0.62 | — | -100.0% |
| EPS (Diluted) | -$0.62 | — | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $87.5M | -6.4% | -31.2% |
| Accounts Receivable | $93.3M | +4.3% | +10.4% |
| Inventory | $43.5M | +5.7% | +10.1% |
| Current Assets | $631.7M | -2.3% | -42.0% |
| Total Assets | $787.9M | -2.0% | -36.9% |
| Current Liabilities | $217.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.5M | — | +62.1% |
| Capital Expenditures | $5.2M | — | -51.4% |
| Investing Cash Flow | $7.7M | — | +219.7% |
| Financing Cash Flow | -$166K | — | -103.2% |
| Free Cash Flow | -$18.7M | — | +59.7% |
| -70.7% |
| Total Liabilities | $457.2M | -1.4% | -48.4% |
| Stockholders' Equity | $330.7M | -2.9% | -8.6% |